Revista espanola de cardiologia (English ed.)
Impact of SGLT2 inhibitors on long-term outcomes in TAVI patients with heart failure: a propensity-matched analysis.
Omar Obeidat, Ahmad Alayyat, Abdallah Naser, Fares Ghanem, Ahmad Jabri, Milos Brankovic, Tianze Jiao, Mohammed Ruzieh, Alaq Haddad, Tamas Alexy, Pedro Villablanca, Laith Alhuneafat
Published: 202510.1016/j.rec.2025.10.016
Abstract
INTRODUCTION AND OBJECTIVES: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve outcomes in heart failure (HF), but their role in patients undergoing transcatheter aortic valve implantation (TAVI) remains unclear. A recent randomized trial (D…
Preview only. Read the full abstract at the source